187O Capivasertib and fulvestrant for patients (pts) with aromatase inhibitor (AI)-resistant HR+/HER2– advanced breast cancer (ABC): Subgroup analyses from the phase III CAPItello-291 trial

التفاصيل البيبلوغرافية
العنوان:	187O Capivasertib and fulvestrant for patients (pts) with aromatase inhibitor (AI)-resistant HR+/HER2– advanced breast cancer (ABC): Subgroup analyses from the phase III CAPItello-291 trial
المؤلفون:	Oliveira, M., Rugo, H.S., Howell, S.J., Dalenc, F., Cortés, J., Moreno, H.L. Gomez, Hu, X., Jhaveri, K., Loibl, S., Morales, S., Okera, M., Park, Y.H., Sohn, J., Tokunaga, E., Zhukova, L., Wadsworth, I., Schiavon, G., Foxley, A., Turner, N.
المصدر:	In ESMO Open May 2023 8(1) Supplement 4
قاعدة البيانات:	ScienceDirect

الوصف
تدمد:	20597029
DOI:	10.1016/j.esmoop.2023.101376